Toggle navigation
Home
Search
Services
Blog
Contact
About
Isolation and Study of New Mammalian DNA Repair Enzyme
Toney, Jeffrey Howard
Dana-Farber Cancer Institute, Boston, MA, United States
Search 4 grants from Jeffrey Toney
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Testing the role of BATF as a pioneer transcription factor in effector T cells
A novel genetic pathway for survival of B-lymphoblastic leukemia-initiating cells
Novel Technologies for Investigation of Self-reactive T cells in MS and Relevant
Epidemiology of Aging and Dementia - Autopsy Research
Methoxyindoles in Retina: Function and Regulation
Recently added grants:
Program 30: Neuro-Oncology
Genetic Regulation of Cochlear Development
Afferent-efferent interactions in the developing cochlea
Modeling Genetic Inner Ear Disorders with Human Pluripotent Stem Cells
Program 32: Gastrointestinal Malignancies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA007951-01
Application #
3032928
Study Section
(BI)
Project Start
1986-04-09
Project End
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
Related projects
NIH 1987
F32 CA
Isolation and Study of New Mammalian DNA Repair Enzyme
Toney, Jeffrey Howard / Dana-Farber Cancer Institute
NIH 1985
F32 CA
Isolation and Study of New Mammalian DNA Repair Enzyme
Toney, Jeffrey Howard / Dana-Farber Cancer Institute
Publications
Toney, J H; Donahue, B A; Kellett, P J et al.
(1989)
Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II)
Proc Natl Acad Sci U S A 86:8328-32
Comments
Be the first to comment on Jeffrey Toney's grant